Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 2
2009 1
2011 7
2012 10
2013 7
2014 8
2015 3
2016 11
2017 10
2018 14
2019 13
2020 14
2021 7
2022 1
2023 3
2024 2
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

94 results

Results by year

Filters applied: . Clear all
Page 1
Addendum „Antivirale Therapie der chronischen Hepatitis-D-Virusinfektion“ zur S3-Leitlinie „Prophylaxe, Diagnostik und Therapie der Hepatitis-B-Virusinfektion“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS).
Sandmann L, Berg T, Deterding K, Fischer N, Hinrichsen H, Petersen J, Tacke F, Cornberg M; Collaborators. Sandmann L, et al. Z Gastroenterol. 2023 Dec;61(12):1635-1653. doi: 10.1055/a-2181-3046. Epub 2023 Dec 11. Z Gastroenterol. 2023. PMID: 38081179 Free article. German. No abstract available.
S3-Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) zur Prophylaxe, Diagnostik und Therapie der Hepatitis-B-Virusinfektion – (AWMF-Register-Nr. 021-11).
Cornberg M, Sandmann L, Protzer U, Niederau C, Tacke F, Berg T, Glebe D, Jilg W, Wedemeyer H, Wirth S, Höner Zu Siederdissen C, Lynen-Jansen P, van Leeuwen P, Petersen J; Collaborators:. Cornberg M, et al. Z Gastroenterol. 2021 Jul;59(7):691-776. doi: 10.1055/a-1498-2512. Epub 2021 Jul 12. Z Gastroenterol. 2021. PMID: 34255317 Free article. German. No abstract available.
Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patients.
Dietz J, Graf C, Berg CP, Port K, Deterding K, Buggisch P, Peiffer KH, Vermehren J, Dultz G, Geier A, Reiter FP, Bruns T, Schattenberg JM, Durmashkina E, Gustot T, Moreno C, Trauth J, Discher T, Fischer J, Berg T, Kremer AE, Müllhaupt B, Zeuzem S, Sarrazin C; European HCV Resistance Study Group. Dietz J, et al. Among authors: vermehren j. JHEP Rep. 2024 Mar 25;6(7):101072. doi: 10.1016/j.jhepr.2024.101072. eCollection 2024 Jul. JHEP Rep. 2024. PMID: 39006503 Free PMC article.
Hepatic sarcoidosis: Clinical characteristics and outcome.
Graf C, Arncken J, Lange CM, Willuweit K, Schattenberg JM, Seessle J, Lang-Meli J, Böttler T, Dietz J, Wetzstein N, Mondorf A, Vermehren J, Rohde G, Zeuzem S, Pathil A. Graf C, et al. Among authors: vermehren j. JHEP Rep. 2021 Sep 3;3(6):100360. doi: 10.1016/j.jhepr.2021.100360. eCollection 2021 Dec. JHEP Rep. 2021. PMID: 34765958 Free PMC article.
New HCV Therapies and Liver Transplantation.
Werner JM, Vermehren J. Werner JM, et al. Among authors: vermehren j. Transplantation. 2016 Feb;100(2):260-1. doi: 10.1097/TP.0000000000001092. Transplantation. 2016. PMID: 26813409 Review. No abstract available.
Colon capsule endoscopy: current status and future directions.
Tal AO, Vermehren J, Albert JG. Tal AO, et al. Among authors: vermehren j. World J Gastroenterol. 2014 Nov 28;20(44):16596-602. doi: 10.3748/wjg.v20.i44.16596. World J Gastroenterol. 2014. PMID: 25469027 Free PMC article. Review.
The role of resistance in HCV treatment.
Vermehren J, Sarrazin C. Vermehren J, et al. Best Pract Res Clin Gastroenterol. 2012 Aug;26(4):487-503. doi: 10.1016/j.bpg.2012.09.011. Best Pract Res Clin Gastroenterol. 2012. PMID: 23199507 Review.
94 results